IP Library Granted Patent US 8,140,151
Granted Patent B2
US 8,140,151 · App. 12/770,697 · Granted Mar 20, 2012

Implantable seizure monitor

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,140,151
App. No.
12/770,697
Granted
Mar 20, 2012
Kind
B2
Abstract

An implantable seizure monitor can include at least one sensing electrode and an electronics module configured to detect, record and/or log neurological events. For example, the electronics module can be configured to detect brainwaves indicative of seizures, such as, for example, epileptic seizures, and to create a log indicating when such seizures occur. The implantable seizure monitor can include a cushioning member made of a soft material and configured to be implantable between the epidermis and cranium of a patient.

Claims (29)

1. A method for detecting neurological events comprising:

sensing brainwaves of a patient;

generating a signal indicative of the sensed brainwaves;

amplifying the signal in an amplifier, the amplifier having a gain adjustable to predetermine an amplitude of the signal that will place the amplifier in saturation; and

determining, by a processor, if a neurological event has occurred based on occurrences of saturation of the amplifier.

2. The method according to claim 1 , wherein determining, by the processor, if the neurological event has occurred includes determining if the neurological event has occurred based on the frequency at which the amplifier saturates.

3. The method according to claim 1 , wherein determining, by the processor, if the neurological event has occurred includes determining if the neurological event has occurred based on the number of times the amplifier saturates in a predetermined number of time windows.

4. The method according to claim 1 , wherein determining, by the processor, if the neurological event has occurred includes:

determining, for each time window in a plurality of contiguous time windows, whether the amplifier is saturated; and

determining whether a ratio of a number of time windows in which the amplifier is saturated and the number of contiguous time windows exceeds a predetermined ratio.

5. A method for calibrating an implantable device including an adjustable gain amplifier, the method comprising:

setting an initial gain of the amplifier;

sensing brainwaves of a patient using the implantable device;

generating a signal indicative of the sensed brainwaves using the implantable device;

amplifying the signal in an amplifier, the amplifier having a gain adjustable to predetermine an amplitude of the signal that will place the amplifier in saturation;

determining, by a processor, occurrences of saturation of the amplifier during normal brain activity;

determining, by the processor, whether the occurrences of saturation of the amplifier during normal brain activity exceed a threshold;

adjusting the gain of the amplifier if the occurrences of saturation of the amplifier during normal brain activity exceed the threshold;

repeating determining, by the processor, occurrences of saturation of the amplifier during normal brain activity;

determining, by the processor, whether the occurrences of saturation of the amplifier during normal brain activity exceed the threshold, and adjusting the gain, until the occurrences of saturation of the amplifier during normal brain activity do not exceed the threshold; and

if the occurrences of saturation of the amplifier during normal brain activity do not exceed the threshold, determining, by the processor, if a neurological event has occurred based on occurrences of saturation of the amplifier.

6. The method of claim 5 , wherein determining, by the processor, whether the occurrences of saturation of the amplifier during normal brain activity exceed a threshold includes determining whether a number of saturations of the amplifier exceeds a threshold number of times during a time interval.

7. The method of claim 5 , wherein the initial gain is a maximum gain value of the amplifier.

8. The method of claim 7 , wherein adjusting the gain of the amplifier includes reducing the gain of the amplifier.

9. The method of claim 5 , further comprising storing the occurrences of saturation of the amplifier during normal brain activity.

10. The method of claim 9 , wherein determining, by the processor, whether the occurrences of saturation of the amplifier during normal brain activity exceed a threshold includes determining whether the stored occurrences of saturation of the amplifier during normal brain activity exceed the threshold.

11. The method of claim 5 , further comprising:

determining, by the processor, whether the occurrences of saturation of the amplifier during normal brain activity does not exceed a minimum value; and

increasing the gain of the amplifier if the occurrences of saturation of the amplifier during normal brain activity does not exceed the minimum value, wherein the repeating includes determining, by the processor, whether the occurrences of saturation of the amplifier during normal brain activity does not exceed a minimum value and increasing the gain of the amplifier.

Assignments (6)
SECURITY INTEREST Recorded Jun 25, 2025
From: NEUROPACE, INC.
To: MIDCAP FUNDING IV TRUST
Reel/Frame 071712/0422 →
RELEASE OF SECURITY INTEREST Recorded Jun 4, 2025
From: CRG SERVICING LLC AS SUCCESSOR TO CAPITAL ROYALTY PARTNERS II L.P., CAPITAL ROYALTY PARTNERS II - PARALLEL FUND "A" L.P., AND PARALLEL INVESTMENT OPPORTUNITIES PARTNERS II L.P.
To: NEUROPACE INC.
Reel/Frame 071495/0800 →
SECURITY INTEREST Recorded Sep 25, 2020
From: NEUROPACE, INC.
To: CRG SERVICING LLC
Reel/Frame 053885/0932 →
SHORT-FORM PATENT SECURITY AGREEMENT Recorded Nov 20, 2014
From: NEUROPACE, INC.
To: CAPITAL ROYALTY PARTNERS II L.P.; CAPITAL ROYALTY PARTNERS II - PARALLEL FUND "A" L.P.; PARALLEL INVESTMENT OPPORTUNITIES PARTNERS II L.P.
Reel/Frame 034410/0767 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 30, 2010
From: GREENE, DAVID
To: NEUROPACE, INC.
Reel/Frame 024318/0597 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 29, 2010
From: GREENE, DAVID
To: NEUROPACE, INC.
Reel/Frame 024313/0691 →